CDK-TCIP2
DK-TCIP2 is a bifunctional small molecule research compound combining a CDK9 inhibitor with a BCL6 inhibitor. It demonstrates potent anticancer activity in both in vitro and in vivo models, making it a valuable tool for investigating therapeutic strategies in lymphoma research.
Product Specifications
Field of Research
Cell Biology, Immunology & Inflammation
Molecular Formula
C52H67ClN12O8S2
Molecular Weight
1087.75
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K7447803 1.0 µg DNA
Ncbp1 sgRNA CRISPR Lentivector (Rat) (Target 2)
Sign In for Pricing
View Details 
134180-ML490 100 µL
TAF15 (RBP56, TAF2N, TATA-binding Protein-associated Factor 2N, 68kD TATA-binding Protein-associated Factor, RNA-binding Protein 56, TAF (II) 68, TAFII68) (MaxLight 490)
Sign In for Pricing
View Details 
GTR15331954 1 Vial
Lentiviral human CPA6 shRNA (UAS) - Lentiviral human CPA6 shRNA (UAS) plasmid
Sign In for Pricing
View Details